Capital Increase / Dilution2026-08-13

DAVOLINK Amends Capital Increase Schedule

DAV

다보링크

340360

+0.05

Signal Score

50CNeutral
Score50 / 100

Historical Avg Return (5d)

+0.00%

Data Coverage

100%n=2755

Risk-adjusted indicator based on 2755 historical DART filings. For informational purposes only — not investment advice.

Financial Impact

NEUTRAL

Key Numbers

  • • New Share Certificate Delivery Date (Amended): September 8, 2026
  • • New Share Listing Date (Amended): September 8, 2026
  • • Original Filing Date: January 20, 2026
  • • Subscription Date: July 24, 2026
  • • Discount Rate: Within 10% of weighted average stock price

AI Analysis Summary

DAVOLINK Inc. announced an amendment to its Material Fact Report regarding a paid-in capital increase. The new share certificate delivery date and new share listing date have both been adjusted from August 20, 2026, to September 8, 2026. This capital increase is a small-scale public offering, under 1B KRW, not requiring a securities registration statement. The issuance price will be determined using a discount rate of up to 10% from the weighted average stock price. The subscription date is July 24, 2026. This amendment primarily concerns a schedule change, indicating no new dilution details or significant financial impact beyond the initial capital increase plan.

How This Event Is Evaluated

Capital Raise Evaluation

Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.

AI is used to interpret disclosures and extract structured data.

Signal scores are generated using event-specific methodologies and quantitative models.

  • Potential dilution rate
  • Issuance or conversion price
  • Funding purpose
  • Shareholder value impact
Read our full scoring methodology →

This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.

AI-processed analysis. Based on: [기재정정]주요사항보고서(유상증자결정). Source: Financial Supervisory Service (금융감독원 전자공시시스템). Raw government data is not redistributed. Not investment advice.